{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:03:07Z","timestamp":1790866987352,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T00:00:00Z","timestamp":1516320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T00:00:00Z","timestamp":1516320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study assesses the efficacy and exposure\u2013response relationship of omega-3-carboxylic acids (OM-3 CA) in models of crystal-based inflammation. Human THP-1 macrophages and primary peripheral blood mononuclear cells exposed to multiple inflammatory crystal types were used to determine the anti-inflammatory potential of omega-3 (OM-3) fatty acids <jats:italic>in vitro<\/jats:italic>. Anti-inflammatory effects of OM-3 CA <jats:italic>in vivo<\/jats:italic> were tested in rat monosodium urate (MSU) crystal air pouch and rat knee intra-articular MSU injection models. Acute treatment with the OM-3 fatty acid docosahexaenoic acid suppressed MSU-, cholesterol crystal-, and calcium pyrophosphate crystal-mediated interleukin-1\u03b2 (IL-1\u03b2) production <jats:italic>in vitro<\/jats:italic>. <jats:italic>In vivo<\/jats:italic>, OM-3 CA dose-dependently reduced crystal-mediated cell migration, exudate volume, and levels of IL-1\u03b2 and prostaglandin E<jats:sub>2<\/jats:sub>. Following intra-articular injection of MSU, treatment with OM-3-CA (1\u2009mL\/kg) and indomethacin (1\u2009mg\/kg) resulted in similar mean reductions in pain (23% and 41%, respectively) and swelling (58% and 50%, respectively), compared with controls. Additionally, in complex formulations of OM-3 fatty acids, high levels of palmitic acid could reduce the <jats:italic>in vivo<\/jats:italic> effect on crystal-mediated IL-1\u03b2 elevation. OM-3 CA has a broadly efficacious anti-inflammatory effect with a strong exposure\u2013response relationship that could be beneficial in prevention and treatment of crystal arthritis, with potential applications in other IL-1\u03b2-mediated diseases.<\/jats:p>","DOI":"10.1038\/s41598-018-19252-x","type":"journal-article","created":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T11:47:55Z","timestamp":1516016875000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Omega-3-carboxylic acids provide efficacious anti-inflammatory activity in models of crystal-mediated inflammation"],"prefix":"10.1038","volume":"8","author":[{"given":"Cory","family":"Iverson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bacong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"Lundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Oscarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Miner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,19]]},"reference":[{"key":"19252_CR1","doi-asserted-by":"publisher","first-page":"27i","DOI":"10.1016\/j.amjcard.2005.12.024","volume":"98","author":"MH Davidson","year":"2006","unstructured":"Davidson, M. H. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 98, 27i\u201333i (2006).","journal-title":"Am J Cardiol"},{"key":"19252_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1056\/NEJM198902023200501","volume":"320","author":"S Endres","year":"1989","unstructured":"Endres, S., Ghorbani, R. & Kelley, V. E. et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. The New England journal of medicine 320, 265\u2013271 (1989).","journal-title":"The New England journal of medicine"},{"key":"19252_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","volume":"142","author":"DY Oh","year":"2010","unstructured":"Oh, D. Y., Talukdar, S. & Bae, E. J. et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687\u2013698 (2010).","journal-title":"Cell"},{"issue":"Suppl","key":"19252_CR4","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1007\/BF02637046","volume":"31","author":"DR Robinson","year":"1996","unstructured":"Robinson, D. R., Urakaze, M. & Huang, R. et al. Dietary marine lipids suppress continuous expression of interleukin-1 beta gene transcription. Lipids 31(Suppl), S23\u201331 (1996).","journal-title":"Lipids"},{"key":"19252_CR5","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","volume":"38","author":"Y Yan","year":"2013","unstructured":"Yan, Y., Jiang, W. & Spinetti, T. et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38, 1154\u20131163 (2013).","journal-title":"Immunity"},{"key":"19252_CR6","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/art.1780300905","volume":"30","author":"RI Sperling","year":"1987","unstructured":"Sperling, R. I., Weinblatt, M. & Robin, J. L. et al. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arthritis and rheumatism 30, 988\u2013997 (1987).","journal-title":"Arthritis and rheumatism"},{"key":"19252_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2222.1988.tb02857.x","volume":"18","author":"CM Kirsch","year":"1988","unstructured":"Kirsch, C. M., Payan, D. G. & Wong, M. Y. et al. Effect of eicosapentaenoic acid in asthma. Clinical allergy 18, 177\u2013187 (1988).","journal-title":"Clinical allergy"},{"key":"19252_CR8","first-page":"1471","volume":"15","author":"LG Cleland","year":"1988","unstructured":"Cleland, L. G., French, J. K., Betts, W. H., Murphy, G. A. & Elliott, M. J. Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. The Journal of rheumatology 15, 1471\u20131475 (1988).","journal-title":"The Journal of rheumatology"},{"key":"19252_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-2796.1989.tb01461.x","volume":"731","author":"R Lorenz","year":"1989","unstructured":"Lorenz, R. et al. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease \u2013 a randomized, placebo-controlled, double-blind cross-over trial. Journal of internal medicine. Supplement 731, 225\u2013232 (1989).","journal-title":"Journal of internal medicine. Supplement"},{"key":"19252_CR10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1136\/gut.33.7.922","volume":"33","author":"AB Hawthorne","year":"1992","unstructured":"Hawthorne, A. B., Daneshmend, T. K. & Hawkey, C. J. et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 33, 922\u2013928 (1992).","journal-title":"Gut"},{"key":"19252_CR11","doi-asserted-by":"crossref","unstructured":"Kris-Etherton, P. M., Harris, W. S., Appel, L. J. & American Heart Association. Nutrition, C. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747\u20132757 (2002).","DOI":"10.1161\/01.CIR.0000038493.65177.94"},{"key":"19252_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/CS20040119","volume":"107","author":"PC Calder","year":"2004","unstructured":"Calder, P. C. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clinical science 107, 1\u201311 (2004).","journal-title":"Clinical science"},{"key":"19252_CR13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0889-857X(21)00465-8","volume":"21","author":"RI Sperling","year":"1995","unstructured":"Sperling, R. I. Eicosanoids in rheumatoid arthritis. Rheumatic diseases clinics of North America 21, 741\u2013758 (1995).","journal-title":"Rheumatic diseases clinics of North America"},{"key":"19252_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.pain.2007.01.020","volume":"129","author":"RJ Goldberg","year":"2007","unstructured":"Goldberg, R. J. & Katz, J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 129, 210\u2013223 (2007).","journal-title":"Pain"},{"issue":"Suppl 2","key":"19252_CR15","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.1017\/S0007114512001560","volume":"107","author":"EA Miles","year":"2012","unstructured":"Miles, E. A. & Calder, P. C. Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. The British journal of nutrition 107(Suppl 2), S171\u2013184 (2012).","journal-title":"The British journal of nutrition"},{"key":"19252_CR16","doi-asserted-by":"publisher","first-page":"27384","DOI":"10.1074\/jbc.M109.044065","volume":"284","author":"SW Wong","year":"2009","unstructured":"Wong, S. W. et al. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. The Journal of biological chemistry 284, 27384\u201327392 (2009).","journal-title":"The Journal of biological chemistry"},{"key":"19252_CR17","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.4049\/jimmunol.174.9.5390","volume":"174","author":"AR Weatherill","year":"2005","unstructured":"Weatherill, A. R. et al. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. Journal of immunology 174, 5390\u20135397 (2005).","journal-title":"Journal of immunology"},{"key":"19252_CR18","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","volume":"192","author":"CN Serhan","year":"2000","unstructured":"Serhan, C. N. et al. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. The Journal of experimental medicine 192, 1197\u20131204 (2000).","journal-title":"The Journal of experimental medicine"},{"key":"19252_CR19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.5650\/jos.62.883","volume":"62","author":"N Ding","year":"2013","unstructured":"Ding, N., Xue, Y. & Tang, X. et al. Short-term effects of different fish oil formulations on tissue absorption of docosahexaenoic acid in mice fed high- and low-fat diets. J Oleo Sci 62, 883\u2013891 (2013).","journal-title":"J Oleo Sci"},{"key":"19252_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMcp1001124","volume":"364","author":"T Neogi","year":"2011","unstructured":"Neogi, T. Clinical practice. Gout. The New England journal of medicine 364, 443\u2013452 (2011).","journal-title":"Gout. The New England journal of medicine"},{"key":"19252_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semarthrit.2014.02.003","volume":"44","author":"PP Khanna","year":"2014","unstructured":"Khanna, P. P., Gladue, H. S. & Singh, M. K. et al. Treatment of acute gout: a systematic review. Seminars in arthritis and rheumatism 44, 31\u201338 (2014).","journal-title":"Seminars in arthritis and rheumatism"},{"key":"19252_CR22","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/annrheumdis-2015-208767","volume":"75","author":"A Abhishek","year":"2016","unstructured":"Abhishek, A., Valdes, A. M. & Doherty, M. Low omega-3 fatty acid levels associate with frequent gout attacks: a case control study. Annals of the rheumatic diseases 75, 784\u2013785 (2016).","journal-title":"Annals of the rheumatic diseases"},{"key":"19252_CR23","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1002\/art.1780311211","volume":"31","author":"GA Tate","year":"1988","unstructured":"Tate, G. A., Mandell, B. F. & Karmali, R. A. et al. Suppression of monosodium urate crystal-induced acute inflammation by diets enriched with gamma-linolenic acid and eicosapentaenoic acid. Arthritis and rheumatism 31, 1543\u20131551 (1988).","journal-title":"Arthritis and rheumatism"},{"key":"19252_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1476-5381.1987.tb08971.x","volume":"90","author":"PM Brooks","year":"1987","unstructured":"Brooks, P. M., Burton, D. & Forrest, M. J. Crystal-induced inflammation in the rat subcutaneous air-pouch. British journal of pharmacology 90, 413\u2013419 (1987).","journal-title":"British journal of pharmacology"},{"key":"19252_CR25","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/art.10326","volume":"46","author":"C Schiltz","year":"2002","unstructured":"Schiltz, C., Liote, F. & Prudhommeaux, F. et al. Monosodium urate monohydrate crystal-induced inflammation in vivo: quantitative histomorphometric analysis of cellular events. Arthritis and rheumatism 46, 1643\u20131650 (2002).","journal-title":"Arthritis and rheumatism"},{"key":"19252_CR26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1213\/00000539-199908000-00029","volume":"89","author":"H Buerkle","year":"1999","unstructured":"Buerkle, H., Pogatzki, E. & Pauser, M. et al. Experimental arthritis in the rat does not alter the analgesic potency of intrathecal or intraarticular morphine. Anesthesia and analgesia 89, 403\u2013408 (1999).","journal-title":"Anesthesia and analgesia"},{"key":"19252_CR27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/bja\/83.3.436","volume":"83","author":"H Buerkle","year":"1999","unstructured":"Buerkle, H. et al. Thermal and mechanical antinociceptive action of spinal vs peripherally administered clonidine in the rat inflamed knee joint model. British journal of anaesthesia 83, 436\u2013441 (1999).","journal-title":"British journal of anaesthesia"},{"key":"19252_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jacl.2013.10.003","volume":"8","author":"JJ Kastelein","year":"2014","unstructured":"Kastelein, J. J., Maki, K. C. & Susekov, A. et al. Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial. Journal of clinical lipidology 8, 94\u2013106 (2014).","journal-title":"Journal of clinical lipidology"},{"key":"19252_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1517\/14656566.2015.991307","volume":"16","author":"EM Roth","year":"2015","unstructured":"Roth, E. M. Omega-3 carboxylic acids for hypertriglyceridemia. Expert opinion on pharmacotherapy 16, 123\u2013133 (2015).","journal-title":"Expert opinion on pharmacotherapy"},{"key":"19252_CR30","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jacl.2012.01.002","volume":"6","author":"MH Davidson","year":"2012","unstructured":"Davidson, M. H., Johnson, J., Rooney, M. W., Kyle, M. L. & Kling, D. F. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova\u00ae compared to Lovaza\u00ae in a pharmacokinetic single-dose evaluation) study. Journal of clinical lipidology 6, 573\u2013584 (2012).","journal-title":"Journal of clinical lipidology"},{"key":"19252_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"19252_CR32","doi-asserted-by":"publisher","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","volume":"5","author":"K Rajamaki","year":"2010","unstructured":"Rajamaki, K., Lappalainen, J. & Oorni, K. et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PloS one 5, e11765 (2010).","journal-title":"PloS one"},{"key":"19252_CR33","doi-asserted-by":"crossref","unstructured":"Maki, K. C., Orloff, D. G., Nicholls, S. J. et al. A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial). Clinical therapeutics 35, 1400\u20131411.e1401\u20131403 (2013).","DOI":"10.1016\/j.clinthera.2013.07.420"},{"key":"19252_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/1056-8719(94)90067-1","volume":"32","author":"SW Martin","year":"1994","unstructured":"Martin, S. W. et al. The six-day-old rat air pouch model of inflammation: characterization of the inflammatory response to carrageenan. Journal of pharmacological and toxicological methods 32, 139\u2013147 (1994).","journal-title":"Journal of pharmacological and toxicological methods"},{"key":"19252_CR35","first-page":"54","volume":"3","author":"CW Denko","year":"1976","unstructured":"Denko, C. W. & Whitehouse, M. W. Experimental inflammation induced by naturally occurring microcrystalline calcium salts. The Journal of rheumatology 3, 54\u201362 (1976).","journal-title":"The Journal of rheumatology"},{"key":"19252_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11926-001-0049-7","volume":"3","author":"RC Landis","year":"2001","unstructured":"Landis, R. C. & Haskard, D. O. Pathogenesis of crystal-induced inflammation. Current rheumatology reports 3, 36\u201341 (2001).","journal-title":"Current rheumatology reports"},{"key":"19252_CR37","unstructured":"Terkeltaub, R. Pathogenesis and treatment of crystal-induced inflammation in Arthritis and Allied Conditions (ed. Koopman, W. J. & Moreland, L. W.) 2357 (Lippincott Williams & Wilkins, 2004)."},{"key":"19252_CR38","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1182\/blood.V91.5.1769","volume":"91","author":"M Pouliot","year":"1998","unstructured":"Pouliot, M., James, M. J., McColl, S. R., Naccache, P. H. & Cleland, L. G. Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 91, 1769\u20131776 (1998).","journal-title":"Blood"},{"key":"19252_CR39","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/acr.21773","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna, D., Khanna, P. P. & Fitzgerald, J. D. et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis care & research 64, 1447\u20131461 (2012).","journal-title":"Arthritis care & research"},{"key":"19252_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nm.3547","volume":"20","author":"C Schauer","year":"2014","unstructured":"Schauer, C., Janko, C. & Munoz, L. E. et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nature medicine 20, 511\u2013517 (2014).","journal-title":"Nature medicine"},{"key":"19252_CR41","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/bjp.2008.20","volume":"153","author":"EW Chia","year":"2008","unstructured":"Chia, E. W., Grainger, R. & Harper, J. L. Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine. British journal of pharmacology 153, 1288\u20131295 (2008).","journal-title":"British journal of pharmacology"},{"key":"19252_CR42","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/art.27327","volume":"62","author":"RA Terkeltaub","year":"2010","unstructured":"Terkeltaub, R. A. et al. High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis and rheumatism 62, 1060\u20131068 (2010).","journal-title":"Arthritis and rheumatism"},{"key":"19252_CR43","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1136\/ard.2009.109355","volume":"68","author":"R Torres","year":"2009","unstructured":"Torres, R., Macdonald, L. & Croll, S. D. et al. Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis. Annals of the rheumatic diseases 68, 1602\u20131608 (2009).","journal-title":"Annals of the rheumatic diseases"},{"key":"19252_CR44","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/ard.2010.139360","volume":"70","author":"W Zhang","year":"2011","unstructured":"Zhang, W., Doherty, M. & Pascual, E. et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Annals of the rheumatic diseases 70, 571\u2013575 (2011).","journal-title":"Annals of the rheumatic diseases"},{"key":"19252_CR45","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jbspin.2004.12.010","volume":"72","author":"R Liu-Bryan","year":"2005","unstructured":"Liu-Bryan, R. & Liote, F. Monosodium urate and calcium pyrophosphate dihydrate (CPPD) crystals, inflammation, and cellular signaling. Joint, bone, spine: revue du rhumatisme 72, 295\u2013302 (2005).","journal-title":"Joint, bone, spine: revue du rhumatisme"},{"key":"19252_CR46","doi-asserted-by":"publisher","first-page":"R192","DOI":"10.1186\/ar3163","volume":"12","author":"MH Cardiel","year":"2010","unstructured":"Cardiel, M. H., Tak, P. P. & Bensen, W. et al. A phase 2 randomized, double-blind study of AMG 108, a fully human monoclonal antibody to IL-1R, in patients with rheumatoid arthritis. Arthritis research & therapy 12, R192 (2010).","journal-title":"Arthritis research & therapy"},{"key":"19252_CR47","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/ard.2003.016014","volume":"63","author":"SB Cohen","year":"2004","unstructured":"Cohen, S. B., Moreland, L. W. & Cush, J. J. et al. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Annals of the rheumatic diseases 63, 1062\u20131068 (2004).","journal-title":"Annals of the rheumatic diseases"},{"key":"19252_CR48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep.24341","volume":"54","author":"T Csak","year":"2011","unstructured":"Csak, T. et al. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54, 133\u2013144 (2011).","journal-title":"Hepatology"},{"key":"19252_CR49","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/ni.2022","volume":"12","author":"H Wen","year":"2011","unstructured":"Wen, H., Gris, D. & Lei, Y. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nature immunology 12, 408\u2013415 (2011).","journal-title":"Nature immunology"},{"key":"19252_CR50","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1002\/jcp.25029","volume":"230","author":"Y Shikama","year":"2015","unstructured":"Shikama, Y., Kudo, Y., Ishimaru, N. & Funaki, M. Possible Involvement of Palmitate in Pathogenesis of Periodontitis. Journal of cellular physiology 230, 2981\u20132989 (2015).","journal-title":"Journal of cellular physiology"},{"key":"19252_CR51","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.3748\/wjg.v22.i8.2533","volume":"22","author":"YH Sui","year":"2016","unstructured":"Sui, Y. H., Luo, W. J., Xu, Q. Y. & Hua, J. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation. World journal of gastroenterology 22, 2533\u20132544 (2016).","journal-title":"World journal of gastroenterology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19252-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19252-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19252-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T01:15:09Z","timestamp":1671585309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19252-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,19]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19252"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-19252-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,19]]},"assertion":[{"value":"12 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.I. is an employee of Ironwood Pharmaceuticals. A.B., S.B., S.L., and J.N.M. are former employees of Ardea Biosciences. T.L. and J.O. are employees of AstraZeneca.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1217"}}